HCPCS Level II › Q codes › Q2055

Q2055

Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

ValidHCPCS Level II code.

Valid for claims with a date of service in the current code year.

Valid FY2023 onwards.

What has happened to this code

Every change the publisher made, from 2024 to now.

  1. July 2024 Description revised Idecabtagene vicleucel, up to 460 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose